These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 13374116)

  • 61. [Blockade of dextran-anuria in water deprived rats through the serotonin antagonists lysergic acid diethylamide and 1-methyl-lysergic acid butanolamide].
    Taborsky J
    Med Pharmacol Exp Int J Exp Med; 1967; 17(1):6-10. PubMed ID: 6072683
    [No Abstract]   [Full Text] [Related]  

  • 62. [On the mechanism of lysergic acid diethylamide (LSD) action on the central nervous system].
    Anokhina IP
    Fiziol Zh SSSR Im I M Sechenova; 1967 Sep; 53(9):1016-25. PubMed ID: 5615978
    [No Abstract]   [Full Text] [Related]  

  • 63. [Experimental contribution to the problem of possible crossed tolerance between psychotic drugs of different structure].
    MISSERE G; TONINI G
    Boll Soc Ital Biol Sper; 1959 Sep; 35():1119-20. PubMed ID: 14422940
    [No Abstract]   [Full Text] [Related]  

  • 64. [Drugs and their effects].
    Huyghe B
    Arch Belg Med Soc; 1971 May; 29(5):303-37. PubMed ID: 5158147
    [No Abstract]   [Full Text] [Related]  

  • 65. The inhibition of human brain acetylcholinesterase by LSD-25 and JB-336 in vitro.
    Bajgar J; Patocka J; Zizkovský V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1971; 14(4):417-23. PubMed ID: 5291385
    [No Abstract]   [Full Text] [Related]  

  • 66. Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine.
    Horita A; Hamilton AE
    Science; 1969 Apr; 164(3875):78-9. PubMed ID: 5773714
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Central and peripheral adrenergic blocking actions of LSD and BOL.
    Palmer GC; Burks TF
    Eur J Pharmacol; 1971 Sep; 16(1):113-6. PubMed ID: 4400508
    [No Abstract]   [Full Text] [Related]  

  • 68. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. LYSERGIC ACID DIETHYLAMIDE (LSD-25). XXXV. COMPARISON OF EFFECT ON SIAMESE FIGHTING FISH AND GOLDFISH.
    GETTNER HH; ROLO A; ABRAMSON HA
    J Psychol; 1964 Jul; 58():57-63. PubMed ID: 14163636
    [No Abstract]   [Full Text] [Related]  

  • 70. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 71. Action of d-lysergic acid diethylamide on lateral geniculate synapses.
    BISHOP PO; FIELD G; HENNESSY BL; SMITH JR
    J Neurophysiol; 1958 Nov; 21(6):529-49. PubMed ID: 13599045
    [No Abstract]   [Full Text] [Related]  

  • 72. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE; Borsy J; Balogh T
    Acta Pharm Hung; 1973 Sep; 43(5):200-6. PubMed ID: 4755753
    [No Abstract]   [Full Text] [Related]  

  • 73. [Mood, behavior and drugs].
    Monti A
    Minerva Med; 1971 May; 62(40 Suppl):33-4. PubMed ID: 5555948
    [No Abstract]   [Full Text] [Related]  

  • 74. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
    Borsy J; Magóné KE; Balogh T; Pik K
    Acta Pharm Hung; 1973 Sep; 43(5):207-17. PubMed ID: 4755754
    [No Abstract]   [Full Text] [Related]  

  • 75. [Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].
    Kohút A; Nicák A
    Bratisl Lek Listy; 1977 Sep; 68(3):336-43. PubMed ID: 912454
    [No Abstract]   [Full Text] [Related]  

  • 76. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Teratogenic action of LSD-25 on the central nervous system in mouse fetuses].
    Araszkiewicz H; Bartel H
    Folia Morphol (Warsz); 1972; 31(4):565-74. PubMed ID: 4539123
    [No Abstract]   [Full Text] [Related]  

  • 79. [Studies on the effect of certain neurohormones and psychotropic drugs on bioelectric activity of the central nervous system and behavior in ants (Formica rufa L.)].
    Kostowski W; Beck J; Meszaros J
    Acta Physiol Pol; 1966; 17(1):119-33. PubMed ID: 5917788
    [No Abstract]   [Full Text] [Related]  

  • 80. Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors.
    Pierce PA; Peroutka SJ
    Neuropsychopharmacology; 1990; 3(5-6):503-8. PubMed ID: 2078283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.